183 related articles for article (PubMed ID: 15961704)
1. Processes involved in the site-specific effect of probucol on atherosclerosis in apolipoprotein E gene knockout mice.
Choy K; Beck K; Png FY; Wu BJ; Leichtweis SB; Thomas SR; Hou JY; Croft KD; Mori TA; Stocker R
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1684-90. PubMed ID: 15961704
[TBL] [Abstract][Full Text] [Related]
2. Effects of probucol on atherosclerosis of apoE-deficient or LDL receptor-deficient mice.
Yoshikawa T; Shimano H; Chen Z; Ishibashi S; Yamada N
Horm Metab Res; 2001 Aug; 33(8):472-9. PubMed ID: 11544561
[TBL] [Abstract][Full Text] [Related]
3. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C
Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083
[TBL] [Abstract][Full Text] [Related]
4. AGI-1067: a multifunctional phenolic antioxidant, lipid modulator, anti-inflammatory and antiatherosclerotic agent.
Sundell CL; Somers PK; Meng CQ; Hoong LK; Suen KL; Hill RR; Landers LK; Chapman A; Butteiger D; Jones M; Edwards D; Daugherty A; Wasserman MA; Alexander RW; Medford RM; Saxena U
J Pharmacol Exp Ther; 2003 Jun; 305(3):1116-23. PubMed ID: 12626663
[TBL] [Abstract][Full Text] [Related]
5. Probucol [4,4'-[(1-methylethylidene)bis(thio)]bis-[2,6-bis(1,1-dimethylethyl)phenol]] inhibits compensatory remodeling and promotes lumen loss associated with atherosclerosis in apolipoprotein E-deficient mice.
Wu BJ; Di Girolamo N; Beck K; Hanratty CG; Choy K; Hou JY; Ward MR; Stocker R
J Pharmacol Exp Ther; 2007 May; 321(2):477-84. PubMed ID: 17293560
[TBL] [Abstract][Full Text] [Related]
6. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of angiotensin II on atherogenesis at the aortic sinus and descending aorta of apolipoprotein-E-deficient mice.
Zhou Y; Chen R; Catanzaro SE; Hu L; Dansky HM; Catanzaro DF
Am J Hypertens; 2005 Apr; 18(4 Pt 1):486-92. PubMed ID: 15831357
[TBL] [Abstract][Full Text] [Related]
8. Atheroprotective and plaque-stabilizing effects of enzymatically modified isoquercitrin in atherogenic apoE-deficient mice.
Motoyama K; Koyama H; Moriwaki M; Emura K; Okuyama S; Sato E; Inoue M; Shioi A; Nishizawa Y
Nutrition; 2009 Apr; 25(4):421-7. PubMed ID: 19026522
[TBL] [Abstract][Full Text] [Related]
9. Oral flavonoid supplementation attenuates atherosclerosis development in apolipoprotein E-deficient mice.
Hishikawa K; Nakaki T; Fujita T
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):442-6. PubMed ID: 15499038
[TBL] [Abstract][Full Text] [Related]
10. Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice.
Yang J; Sato K; Aprahamian T; Brown NJ; Hutcheson J; Bialik A; Perlman H; Walsh K
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1466-73. PubMed ID: 15178561
[TBL] [Abstract][Full Text] [Related]
11. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice.
Massy ZA; Ivanovski O; Nguyen-Khoa T; Angulo J; Szumilak D; Mothu N; Phan O; Daudon M; Lacour B; Drüeke TB; Muntzel MS
J Am Soc Nephrol; 2005 Jan; 16(1):109-16. PubMed ID: 15563564
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of fibroblast growth factor receptor signaling attenuates atherosclerosis in apolipoprotein E-deficient mice.
Raj T; Kanellakis P; Pomilio G; Jennings G; Bobik A; Agrotis A
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1845-51. PubMed ID: 16709940
[TBL] [Abstract][Full Text] [Related]
13. Aorta of ApoE-deficient mice responds to atherogenic stimuli by a prelesional increase and subsequent decrease in the expression of antioxidant enzymes.
't Hoen PA; Van der Lans CA; Van Eck M; Bijsterbosch MK; Van Berkel TJ; Twisk J
Circ Res; 2003 Aug; 93(3):262-9. PubMed ID: 12829615
[TBL] [Abstract][Full Text] [Related]
14. Dextromethorphan reduces oxidative stress and inhibits atherosclerosis and neointima formation in mice.
Liu SL; Li YH; Shi GY; Tang SH; Jiang SJ; Huang CW; Liu PY; Hong JS; Wu HL
Cardiovasc Res; 2009 Apr; 82(1):161-9. PubMed ID: 19189960
[TBL] [Abstract][Full Text] [Related]
15. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions.
Yoshii T; Iwai M; Li Z; Chen R; Ide A; Fukunaga S; Oshita A; Mogi M; Higaki J; Horiuchi M
Hypertens Res; 2006 Jun; 29(6):457-66. PubMed ID: 16940709
[TBL] [Abstract][Full Text] [Related]
16. Reduction of oxidative stress and atherosclerosis in hyperlipidemic rabbits by Dioscorea rhizome.
Chang WC; Yu YM; Wu CH; Tseng YH; Wu KY
Can J Physiol Pharmacol; 2005 May; 83(5):423-30. PubMed ID: 15897924
[TBL] [Abstract][Full Text] [Related]
17. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice.
George J; Afek A; Abashidze A; Shmilovich H; Deutsch V; Kopolovich J; Miller H; Keren G
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2636-41. PubMed ID: 16195475
[TBL] [Abstract][Full Text] [Related]
18. Nebivolol, but not metoprolol, improves endothelial function of the corpus cavernosum in apolipoprotein e-knockout mice.
Baumhäkel M; Schlimmer N; Büyükafsar K; Arikan O; Böhm M
J Pharmacol Exp Ther; 2008 Jun; 325(3):818-23. PubMed ID: 18364472
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice.
Merhi-Soussi F; Kwak BR; Magne D; Chadjichristos C; Berti M; Pelli G; James RW; Mach F; Gabay C
Cardiovasc Res; 2005 Jun; 66(3):583-93. PubMed ID: 15914123
[TBL] [Abstract][Full Text] [Related]
20. PPARalpha, but not PPARgamma, activators decrease macrophage-laden atherosclerotic lesions in a nondiabetic mouse model of mixed dyslipidemia.
Hennuyer N; Tailleux A; Torpier G; Mezdour H; Fruchart JC; Staels B; Fiévet C
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1897-902. PubMed ID: 15994444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
